These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24738794)

  • 1. What is the ke0 and what does it tell me about propofol?
    Cortínez LI
    Anaesthesia; 2014 May; 69(5):399-402. PubMed ID: 24738794
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.
    Seo JH; Goo EK; Song IA; Park SH; Park HP; Jeon YT; Hwang JW
    Anaesthesia; 2013 Dec; 68(12):1232-8. PubMed ID: 24032636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the plasma effect-site equilibrium rate constant (Ke₀) of propofol by fitting time of loss and recovery of consciousness.
    Wu Q; Sun B; Wang S; Zhao L; Qi F
    Biol Pharm Bull; 2013; 36(9):1420-7. PubMed ID: 23803230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
    Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
    Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of general anaesthesia by effect-site target-controlled infusion of propofol: influence of pharmacokinetic model and ke0 value.
    Thomson AJ; Morrison G; Thomson E; Beattie C; Nimmo AF; Glen JB
    Anaesthesia; 2014 May; 69(5):429-35. PubMed ID: 24738800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of propofol to blood components.
    Suarez E; Calvo R; Zamacona MK; Lukas J
    Br J Clin Pharmacol; 2000 Apr; 49(4):380-1. PubMed ID: 10759696
    [No Abstract]   [Full Text] [Related]  

  • 7. Propofol concentrations during the anhepatic phase of living-related donor liver transplantation.
    Takizawa D; Hiraoka H; Nakamura K; Yamamoto K; Horiuchi R
    Clin Pharmacol Ther; 2004 Dec; 76(6):648-9. PubMed ID: 15592336
    [No Abstract]   [Full Text] [Related]  

  • 8. Onset and offset pharmacodynamics of propofol.
    O'Halloran PL; Hosseini-Yeganeh M; McBride LJ; Ramzan I
    Pharmazie; 2004 Jan; 59(1):76-7. PubMed ID: 14964429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state propofol brain:plasma and brain:blood partition coefficients and the effect-site equilibration paradox.
    Dutta S; Matsumoto Y; Muramatsu A; Matsumoto M; Fukuoka M; Ebling WF
    Br J Anaesth; 1998 Sep; 81(3):422-4. PubMed ID: 9861134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol effect-site concentrations: hunt the k(e0).
    Glen JB
    Anesth Analg; 2013 Aug; 117(2):535-6. PubMed ID: 23881380
    [No Abstract]   [Full Text] [Related]  

  • 11. Propofol pharmacokinetics and pharmacodynamics assessed from a cremophor EL formulation.
    Dutta S; Matsumoto Y; Ebling WF
    J Pharm Sci; 1997 Aug; 86(8):967-9. PubMed ID: 9269876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Using of chromatographical methods to study stability, pharmacokinetics and metabolism of propofol (review)].
    Adeishvili-Anguladze LV; Makharadze RV; Kurtsikidze MSh; Abuladze NB; Gabuniia KU
    Georgian Med News; 2009 May; (170):95-100. PubMed ID: 19556652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.
    Thomson AJ; Nimmo AF; Engbers FH; Glen JB
    Anaesthesia; 2014 May; 69(5):420-8. PubMed ID: 24738799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of propofol during liver transplantation in small pigs].
    Mashimo T; Tsuda Y; Ikeda M; Shibuya H; Inagaki Y; Seto T; Yoshiya I
    Masui; 1996 Mar; 45(3):293-7. PubMed ID: 8721126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatographic assay and pharmacokinetic studies of propofol in human serum.
    Emara S; Saleh G; Fathy M; Bakr MA
    Biomed Chromatogr; 1999 Jun; 13(4):299-303. PubMed ID: 10416064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fospropofol assay issues and impact on pharmacokinetic and pharmacodynamic evaluation.
    Shah A; Mistry B; Gibiansky E; Gibiansky L
    Anesth Analg; 2009 Jan; 108(1):382; author reply 382-3. PubMed ID: 19095885
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of intralipid on free propofol fraction assayed in human serum albumin solutions and human plasma.
    Kalitynski R; Dawidowicz AL; Poszytek J
    Acta Pharmacol Sin; 2006 Dec; 27(12):1637-41. PubMed ID: 17112420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid.
    Dawidowicz AL; Kalityński R
    Biomed Chromatogr; 2003 Oct; 17(7):447-52. PubMed ID: 14598328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term stability of propofol in human plasma and blood in different storage conditions.
    Bienert A; Zaba Z; Dyderski S; Ogrodowicz M; Drobnik L
    Acta Pol Pharm; 2005; 62(2):95-7. PubMed ID: 16161348
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma concentration for optimal sedation and total body clearance of propofol in patients after esophagectomy.
    Takizawa D; Sato E; Nishikawa K; Hinohara H; Hiraoka H; Saito S; Goto F; Kunimoto F
    J Anesth; 2005; 19(1):88-90. PubMed ID: 15674525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.